Sequenex
Sequenex is a full-service medtech software development company specializing in connected medical devices, digital health, and SaMD solutions. They focus on rapid deployment, regulatory compliance, and scalable platforms for the diabetes, wearables, and connected devices markets. Their NEX platform offers prebuilt, compliant, and customizable infrastructure to accelerate product development and market entry. Sequenex also develops innovative wearable solutions, non-invasive diagnostic sensors, and AI-powered data analysis platforms for various medical fields including diabetes, MS, cancer, and menopause. They emphasize interoperability, component architecture, and real-time data collection to enhance treatment, early detection, and research.
Industries
Nr. of Employees
small (1-50)
Products
Configurable digital health platform
A modular, device‑agnostic platform including mobile companion apps, patient and clinician dashboards, administrative controls, security features, and automated documentation tools to accelerate SaMD and biosensor application development.
Configurable digital health platform
A modular, device‑agnostic platform including mobile companion apps, patient and clinician dashboards, administrative controls, security features, and automated documentation tools to accelerate SaMD and biosensor application development.
Services
Design and development of medical device software and connected health applications with integrated traceability, regulatory alignment, and mobile/web frontends.
Development of clinical-grade mobile applications and data collection workflows tailored to clinical studies, remote patient monitoring, and clinician dashboards.
Verification and validation services including unit, integration, acceptance testing, automated test execution, and mobile compatibility testing for regulatory evidence.
Design and integration of ML/AI models for predictive analytics, anomaly detection, personalization, and conversational interfaces using biosensor and device data.
Firmware development and embedded engineering for biosensors and wearables to optimize connectivity, power consumption, and device reliability.
Security architecture, privacy controls, and deployment options to support HIPAA, GDPR, and other data-protection requirements for connected medical solutions.
Design and development of medical device software and connected health applications with integrated traceability, regulatory alignment, and mobile/web frontends.
Development of clinical-grade mobile applications and data collection workflows tailored to clinical studies, remote patient monitoring, and clinician dashboards.
Verification and validation services including unit, integration, acceptance testing, automated test execution, and mobile compatibility testing for regulatory evidence.
Design and integration of ML/AI models for predictive analytics, anomaly detection, personalization, and conversational interfaces using biosensor and device data.
Firmware development and embedded engineering for biosensors and wearables to optimize connectivity, power consumption, and device reliability.
Security architecture, privacy controls, and deployment options to support HIPAA, GDPR, and other data-protection requirements for connected medical solutions.
Expertise Areas
- SaMD and connected-device software development
- Clinical mobile applications and remote data collection for trials
- CGM and biosensor-driven application development
- Device and biosensor integration (multi‑sensor aggregation)
Key Technologies
- Bluetooth Low Energy (BLE)
- Near Field Communication (NFC)
- Wi‑Fi
- iOS and Android mobile application development
News & Updates
Abbott’s Proclaim XR SCS integrates with a smartphone app, highlighting the importance of connectivity in modern medical devices.
Advancements in sensor technology are driving the field of remote patient monitoring, with innovative startups expanding capabilities.
Integration of AI and machine learning into wearable devices enhances data analysis, early detection, and personalized healthcare.
Analysis of over-the-counter CGM devices expected to hit the market in 2024.
Guidance on regulatory pathways for mobile medical apps.
Exploration of how 5G technology will influence connected medical devices.
Abbott’s Proclaim XR SCS integrates with a smartphone app, highlighting the importance of connectivity in modern medical devices.
Advancements in sensor technology are driving the field of remote patient monitoring, with innovative startups expanding capabilities.
Integration of AI and machine learning into wearable devices enhances data analysis, early detection, and personalized healthcare.
Analysis of over-the-counter CGM devices expected to hit the market in 2024.
Guidance on regulatory pathways for mobile medical apps.
Exploration of how 5G technology will influence connected medical devices.